spleen tyrosine kinase inhibitors (Merck KGaA)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namespleen tyrosine kinase inhibitors (Merck KGaA)
Drug Alias NameSYK inhibitors (Merck KGaA)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSpleen tyrosine kinase inhibitors
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsLupus Erythematosus, SystemicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck KGaA, Darmstadt, Germany
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck KGaA, Darmstadt, Germany
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, SystemicArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A